• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铜绿假单胞菌与尿路感染之间的相互作用。

Cross-talk between Pseudomonas aeruginosa and urinary tract infections.

作者信息

Yu Xiao-Quan, Gong Yu-Wen, Tian Jun-Qiang, Peng Cheng, Niu Shao-Min, Feng Han-Zhong, You Chong-Ge, Wang Zhi-Ping

机构信息

Institute of Urology, Gansu Province Clinical Research Center for urinary system disease, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, 730030, Gansu, People's Republic of China.

Laboratory Medicine Center, The Second Hospital of Lanzhou University, Lanzhou, 730030, Gansu, People's Republic of China.

出版信息

World J Urol. 2025 Jun 20;43(1):380. doi: 10.1007/s00345-025-05758-3.

DOI:10.1007/s00345-025-05758-3
PMID:40540108
Abstract

Pseudomonas aeruginosa, a key member of the ESKAPE pathogen group, is a common cause of urinary tract infections (UTIs), particularly in patients with indwelling urinary catheters. Due to its large genome, P. aeruginosa has a high potential for genetic mutations, enabling the development of multidrug resistance. Additionally, it produces a variety of virulence factors, which contribute to persistent and often refractory infections. While UTIs caused by Escherichia coli have been extensively studied, those caused by P. aeruginosa remain less well understood. Understanding the mechanisms underlying the occurrence and progression of P. aeruginosa-associated UTIs, as well as the evolution of its antimicrobial resistance, is crucial for developing more effective treatment strategies. This paper provides an overview of the interaction between P. aeruginosa and UTIs, offering insights that could aid in more effective management and eradication of P. aeruginosa in the urinary tract.

摘要

铜绿假单胞菌是ESKAPE病原体组的关键成员,是尿路感染(UTI)的常见病因,尤其是在留置导尿管的患者中。由于其基因组庞大,铜绿假单胞菌具有很高的基因突变潜力,能够产生多重耐药性。此外,它还产生多种毒力因子,这些因子导致持续性且往往难以治愈的感染。虽然由大肠杆菌引起的尿路感染已得到广泛研究,但由铜绿假单胞菌引起的尿路感染仍了解较少。了解铜绿假单胞菌相关尿路感染的发生和进展机制及其抗菌耐药性的演变,对于制定更有效的治疗策略至关重要。本文概述了铜绿假单胞菌与尿路感染之间的相互作用,提供了有助于更有效地管理和根除尿路中铜绿假单胞菌的见解。

相似文献

1
Cross-talk between Pseudomonas aeruginosa and urinary tract infections.铜绿假单胞菌与尿路感染之间的相互作用。
World J Urol. 2025 Jun 20;43(1):380. doi: 10.1007/s00345-025-05758-3.
2
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.根除囊性纤维化患者体内铜绿假单胞菌的抗生素策略。
Cochrane Database Syst Rev. 2017 Apr 25;4(4):CD004197. doi: 10.1002/14651858.CD004197.pub5.
3
Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.标准抗菌药敏试验与生物膜抗菌药敏试验用于指导囊性纤维化患者的抗生素治疗
Cochrane Database Syst Rev. 2017 Oct 5;10(10):CD009528. doi: 10.1002/14651858.CD009528.pub4.
4
D-mannose for preventing and treating urinary tract infections.D-甘露糖防治尿路感染。
Cochrane Database Syst Rev. 2022 Aug 30;8(8):CD013608. doi: 10.1002/14651858.CD013608.pub2.
5
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.支气管镜引导下的囊性纤维化抗菌治疗
Cochrane Database Syst Rev. 2018 Sep 17;9(9):CD009530. doi: 10.1002/14651858.CD009530.pub4.
6
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.根除囊性纤维化患者体内铜绿假单胞菌的抗生素策略。
Cochrane Database Syst Rev. 2009 Oct 7(4):CD004197. doi: 10.1002/14651858.CD004197.pub3.
7
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.根除囊性纤维化患者体内铜绿假单胞菌的抗生素策略。
Cochrane Database Syst Rev. 2006 Jan 25(1):CD004197. doi: 10.1002/14651858.CD004197.pub2.
8
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.针对囊性纤维化患者中耐甲氧西林金黄色葡萄球菌(MRSA)的清除干预措施。
Cochrane Database Syst Rev. 2022 Dec 13;12(12):CD009650. doi: 10.1002/14651858.CD009650.pub5.
9
Types of urethral catheters for management of short-term voiding problems in hospitalised adults.用于管理住院成人短期排尿问题的尿道导管类型。
Cochrane Database Syst Rev. 2004(1):CD004013. doi: 10.1002/14651858.CD004013.pub2.
10
Use and Effectiveness of Antimicrobial Intravesical Treatment for Prophylaxis and Treatment of Recurrent Urinary Tract Infections (UTIs): a Systematic Review.抗菌膀胱内治疗预防和治疗复发性尿路感染(UTIs)的应用及有效性:一项系统评价
Curr Urol Rep. 2018 Aug 9;19(10):78. doi: 10.1007/s11934-018-0834-8.

本文引用的文献

1
Targeting efflux pumps prevents the multi-step evolution of high-level resistance to fluoroquinolone in .靶向外排泵可防止在……中对氟喹诺酮产生高水平耐药性的多步骤演变。
Microbiol Spectr. 2025 Apr;13(4):e0298124. doi: 10.1128/spectrum.02981-24. Epub 2025 Feb 21.
2
Multidrug-resistant bacteria quorum-sensing inhibitors: A particular focus on Pseudomonasaeruginosa.多药耐药菌群体感应抑制剂:特别关注铜绿假单胞菌。
Eur J Med Chem. 2025 Jan 5;281:117008. doi: 10.1016/j.ejmech.2024.117008. Epub 2024 Oct 29.
3
Antibacterial and anti-biofilm efficacy of selenium nanoparticles against Pseudomonas aeruginosa: Characterization and in vitro analysis.
载硒纳米颗粒对铜绿假单胞菌的抑菌和抗生物膜效果:特性分析和体外研究。
Microb Pathog. 2024 Nov;196:106998. doi: 10.1016/j.micpath.2024.106998. Epub 2024 Oct 9.
4
Revealing quorum-sensing networks in Pseudomonas aeruginosa infections through internal and external signals to prevent new resistance trends.通过内外信号揭示铜绿假单胞菌感染中的群体感应网络,以防止新的耐药趋势。
Microbiol Res. 2024 Dec;289:127915. doi: 10.1016/j.micres.2024.127915. Epub 2024 Sep 24.
5
Decoding Pseudomonas aeruginosa: Genomic insights into adaptation, antibiotic resistance, and the enigmatic role of T6SS in interbacterial dynamics.解析铜绿假单胞菌:基因组揭示适应、抗生素耐药性以及 T6SS 在细菌间动态中的神秘作用。
Microb Pathog. 2024 Nov;196:106932. doi: 10.1016/j.micpath.2024.106932. Epub 2024 Sep 18.
6
Efficacy and safety of preventing catheter-associated urinary tract infection by inhibiting catheter bacterial biofilm formation: a multicenter randomized controlled trial.预防导管相关性尿路感染的疗效和安全性:抑制导管细菌生物膜形成的多中心随机对照试验。
Antimicrob Resist Infect Control. 2024 Sep 2;13(1):96. doi: 10.1186/s13756-024-01450-0.
7
Current state and novel outlook on prevention and treatment of rising antibiotic resistance in urinary tract infections.当前尿路感染中抗生素耐药性上升的预防和治疗的现状和新展望。
Pharmacol Ther. 2024 Sep;261:108688. doi: 10.1016/j.pharmthera.2024.108688. Epub 2024 Jul 6.
8
Impact of multidrug resistance on the virulence and fitness of Pseudomonas aeruginosa: a microbiological and clinical perspective.多药耐药性对铜绿假单胞菌毒力和适应性的影响:微生物学和临床视角。
Infection. 2024 Aug;52(4):1235-1268. doi: 10.1007/s15010-024-02313-x. Epub 2024 Jul 2.
9
High efficacy treatment of murine catheter-associated urinary tract infections using the c-di-GMP modulating anti-biofilm compound Disperazol in combination with ciprofloxacin.使用c-di-GMP调节抗生物膜化合物Disperazol联合环丙沙星高效治疗小鼠导管相关尿路感染
Antimicrob Agents Chemother. 2024 Jun 5;68(6):e0148123. doi: 10.1128/aac.01481-23. Epub 2024 May 8.
10
Current and emerging strategies to curb antibiotic-resistant urinary tract infections.遏制耐抗生素尿路感染的当前及新出现策略。
Nat Rev Urol. 2024 Dec;21(12):707-722. doi: 10.1038/s41585-024-00877-9. Epub 2024 May 7.